The High Court has declined special leave to a former Rigby Cooke client who unsuccessfully challenged the law firm’s win in a dispute over a $24.5 million East Melbourne development.
A trial set to start next week in a class action over Sydney’s $3 billion delayed light rail could be pushed off until next year as the parties clash over an eleventh hour bid by the applicant to amend the case.
Airservices Australia has succeeded in overturning a “manifestly unreasonable” $72,450 fine, but otherwise failed in its appeal of a decision which found it breached an enterprise agreement by withdrawing guidelines for standby shifts for air traffic controllers.
A consortium of parmigiano reggiano producers who claim Kraft Foods’ ‘Kraft parmesan cheese’ trade will lead customers to believe the food giant’s cheese is made in Italy have taken their fight to the Federal Court.
Mayfair 101 founder James Mawhinney has sued the Australian Securities and Investments Commission and its deputy chair Sarah Court, alleging the corporate regulator defamed him in a media release issued last month.
The founder of beleaguered investment group Mayfair 101, James Mawhinney, has asked the High Court to overturn his own successful Full Court appeal of a decision that saw him banned from soliciting funds or promoting any financial product for 20 years.
A COVID-19 outbreak aboard the Ruby Princess that left 28 people dead was “something that was very likely to happen” and the cruise should never have sailed, a court heard as a class action trial against Carnival PLC kicked off.
BHP Group has lost its High Court battle to keep foreign investors from an Australian shareholder class action over the devastating collapse of a Brazilian dam.
PTTEP Australia’s appeal of a class action finding that it breached a duty of care to thousands of farmers impacted by the 2009 Montara oil spill has been put on hold amid a fight between the funder and lawyers that is cloaked in confidentiality.
A judge has thrown out competing appeals of a decision finding Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.